Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness. Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and reducing racial and ethnic disparities in mental health care.
Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, originally funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. The MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.
Dr. Simon and his MHRN colleagues have conducted several large studies across MHRN health systems, including:
Dr. Simon sits on the editorial board for the journal General Hospital Psychiatry, and co-chairs the National Academy of Medicine’s Forum on Drug Discovery, Development and Translation.. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990. He is also a professor in the department of Health Systems Science at the Bernard J Tyson Kaiser Permanente School of Medicine and an adjunct professor inPsychiatry and Behavioral Dciences at the University of Washington.
Depression; bipolar disorder; suicide prevention; self-management; treatment adherence
Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.
Von Korff M, Katon W, Lin EH, Simon G, Ludman E, Oliver M, Ciechanowski P, Rutter C, Bush T. Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med. 2005;67(2):233-40. PubMed
Katon W, Lin E, Simon G. Psychologist prescribing. Psychiatr Serv. 2005;56(3):357. PubMed
Von Korff M, Crane P, Lane M, Miglioretti DL, Simon G, Saunders K, Stang P, Brandenburg N, Kessler R. Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain. 2005;113(3):331-9. PubMed
Simon GE, Von Korff M, Lin E. Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol Med. 2005;35(2):271-9. PubMed
Simon GE, Von Korff M. Medical co-morbidity and validity of DSM-IV depression criteria. Psychol Med. 2006;36(1):27-36. Epub 2005 Oct 5. PubMed
Simon GE, Ludman EJ, Unutzer J, Bauer MS, Operskalski B, Rutter C. Randomized trial of a population-based care program for people with bipolar disorder. Psychol Med. 2005;35(1):13-24. PubMed
De Almeida Fleck MP, Simon G, Herrman H, Bushnell D, Martin M, Patrick D. Major depression and its correlates in primary care settings in six countries: 9-month follow-up study. Br J Psychiatry. 2005;186:41-47. PubMed
Kisely S, Simon G. An international study of the effect of physical ill health on psychiatric recovery in primary care. Psychosom Med. 2005;67(1):116-22. PubMed
Simon GE. Symposium IV. The burden of bipolar disorder: medical illness, suicide and cognitive impairment. Bipolar Disord. 2005;7 Suppl 2:19. PubMed
Katon WJ, Unutzer J, Simon G. Treatment of depression in primary care: where we are, where we can go. Med Care. 2004;42(12):1153-7. PubMed
In a new multistate study, the Zero Suicide Model reduced suicide rates by 25%.
Safety planning and risk screening improved outcomes for adult patients.
A new grant funds modeling work to make personalized treatment possible.
KPWHRI research finds ways to increase use of a firearm safety tool.
Study finds that many patients who might benefit from clozapine don’t receive it.